Weiwei Qin
- Topics
- Renal Transplantation Outcomes and Treatments (3 papers)Acute Myeloid Leukemia Research (3 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe Journal of Clinical Endocrinology & MetabolismCancer Research
- Partner nations
- ChinaUnited StatesSlovakia
In The Last Decade
Weiwei Qin
40 papers receiving 494 citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 192
- Immunology 59
- Cardiology and Cardiovascular Medicine 57
- Cancer Research 47
- Physiology 46
Countries citing papers authored by Weiwei Qin
This map shows the geographic impact of Weiwei Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Qin more than expected).
Fields of papers citing papers by Weiwei Qin
This network shows the impact of papers produced by Weiwei Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Qin. The network helps show where Weiwei Qin may publish in the future.
Co-authorship network of co-authors of Weiwei Qin
This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Qin. A scholar is included among the top collaborators of Weiwei Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Qin. Weiwei Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic micebreakdown → | 16 |
| 2 | 0 | |
| 3 | 23 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 6 | |
| 7 | 14 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 39 | |
| 12 | 1 | |
| 13 | 15 | |
| 14 | 15 | |
| 15 | 8 | |
| 16 | 6 | |
| 17 | 19 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 45 |
About Weiwei Qin
Weiwei Qin is a scholar working on Transplantation, Internal Medicine and Geriatrics and Gerontology, having authored 42 papers that have together received 497 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (3 papers), Acute Myeloid Leukemia Research (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Geriatrics and Gerontology (26 citations), Complementary and alternative medicine (29 citations) and Cancer Research (47 citations). Weiwei Qin has collaborated with scholars based in China, United States and Slovakia. Frequent co-authors include Yong Man, Tao Shen, Jian Li, Yonggang Lu, Chuanshi Xiao, Youhe Gao, Yunfei Bian, Ning‐Hua Tan, Wei Han and Zhihao Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.